Qin Y, Zhao W, Li Q, Cai Z, Wang G, Wang N
Iran J Biotechnol. 2024; 22(3):e3693.
PMID: 39737205
PMC: 11682521.
DOI: 10.30498/ijb.2024.394737.3693.
Gascard P, Wang X, Nosrati M, Kim K, Kashani-Sabet M, Tlsty T
Pathol Oncol Res. 2024; 30:1611889.
PMID: 39376672
PMC: 11456440.
DOI: 10.3389/pore.2024.1611889.
Aloliqi A
Molecules. 2024; 29(15).
PMID: 39124881
PMC: 11314437.
DOI: 10.3390/molecules29153476.
Patel A, Yanai I
Cell. 2024; 187(12):2907-2918.
PMID: 38848676
PMC: 11256907.
DOI: 10.1016/j.cell.2024.04.032.
Arndt P, Turkowski K, Cekay M, Eul B, Grimminger F, Savai R
Clin Sci (Lond). 2024; 138(11):617-634.
PMID: 38785410
PMC: 11130555.
DOI: 10.1042/CS20240426.
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
Bhat G, Sethi I, Sadida H, Rah B, Mir R, Algehainy N
Cancer Metastasis Rev. 2024; 43(1):197-228.
PMID: 38329598
PMC: 11016008.
DOI: 10.1007/s10555-024-10172-z.
Enabling personalised disease diagnosis by combining a patient's time-specific gene expression profile with a biomedical knowledge base.
Verma G, Rebholz-Schuhmann D, Madden M
BMC Bioinformatics. 2024; 25(1):62.
PMID: 38326757
PMC: 10848462.
DOI: 10.1186/s12859-024-05674-0.
Targeting the PI3K-Akt-mTOR signaling pathway involved in vasculogenic mimicry promoted by cancer stem cells.
Murai T, Matsuda S
Am J Cancer Res. 2023; 13(11):5039-5046.
PMID: 38058805
PMC: 10695779.
Transcriptional background effects on a tumor driver gene in different pigment cell types of medaka.
Abdulsahib S, Boswell W, Boswell M, Savage M, Schartl M, Lu Y
J Exp Zool B Mol Dev Evol. 2023; 342(3):252-259.
PMID: 37877158
PMC: 11043209.
DOI: 10.1002/jez.b.23224.
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.
Noviello T, Di Giacomo A, Caruso F, Covre A, Mortarini R, Scala G
Nat Commun. 2023; 14(1):5914.
PMID: 37739939
PMC: 10516894.
DOI: 10.1038/s41467-023-40994-4.
Pharmacological Activity of Matrine in Inhibiting Colon Cancer Cells VM Formation, Proliferation, and Invasion by Downregulating Claudin-9 Mediated EMT Process and MAPK Signaling Pathway.
Du Q, Lin Y, Ding C, Wu L, Xu Y, Feng Q
Drug Des Devel Ther. 2023; 17:2787-2804.
PMID: 37719361
PMC: 10504061.
DOI: 10.2147/DDDT.S417077.
VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation.
Delgado-Bellido D, Oliver F, Vargas Padilla M, Lobo-Selma L, Chacon-Barrado A, Diaz-Martin J
Int J Mol Sci. 2023; 24(11).
PMID: 37298296
PMC: 10253758.
DOI: 10.3390/ijms24119343.
TJP1 promotes vascular mimicry in bladder cancer by facilitating VEGFA expression and transcriptional activity through TWIST1.
Dong Z, Chan S, Chen S, Li M, Zhang X, Liu X
Transl Oncol. 2023; 32:101666.
PMID: 37031603
PMC: 10119961.
DOI: 10.1016/j.tranon.2023.101666.
Boolean network sketches: a unifying framework for logical model inference.
Benes N, Brim L, Huvar O, Pastva S, Safranek D
Bioinformatics. 2023; 39(4).
PMID: 37004199
PMC: 10122605.
DOI: 10.1093/bioinformatics/btad158.
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory.
Artusa V, Calabrone L, Mortara L, Peri F, Bruno A
Int J Mol Sci. 2023; 24(5).
PMID: 36902427
PMC: 10003410.
DOI: 10.3390/ijms24054997.
Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry.
Timar J, Honn K, Hendrix M, Marko-Varga G, Jalkanen S
Cancer Metastasis Rev. 2023; 42(1):323-334.
PMID: 36754910
PMC: 10014767.
DOI: 10.1007/s10555-023-10087-1.
New Insights into the Phenotype Switching of Melanoma.
Pagliuca C, Di Leo L, De Zio D
Cancers (Basel). 2022; 14(24).
PMID: 36551603
PMC: 9776915.
DOI: 10.3390/cancers14246118.
Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma.
Han Y, Cai Q, Xie X, Gao S, Fan X
Front Oncol. 2022; 12:1011046.
PMID: 36419893
PMC: 9677727.
DOI: 10.3389/fonc.2022.1011046.
GediNET for discovering gene associations across diseases using knowledge based machine learning approach.
Qumsiyeh E, Showe L, Yousef M
Sci Rep. 2022; 12(1):19955.
PMID: 36402891
PMC: 9675776.
DOI: 10.1038/s41598-022-24421-0.
Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden.
Georgoulias G, Zaravinos A
Front Immunol. 2022; 13:1006665.
PMID: 36389735
PMC: 9650672.
DOI: 10.3389/fimmu.2022.1006665.